Thermo Fisher Scientific to Present at 35th Annual J.P. Morgan Healthcare Conference on January 10, 2017
Tuesday, January 3, 2017 8:30 am EST
 

Dateline:

WALTHAM, Mass.

Public Company Information:

NYSE:
TMO
 

WALTHAM, Mass.--(Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the 35th Annual J. P. Morgan Healthcare Conference on Tuesday, January 10, 2017, at 2:30 p.m. (PST) at the Westin St. Francis, San Francisco, Calif.

You can access the live webcast of the presentations via the Investors section of our website, www.thermofisher.com.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of $17 billion and more than 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

 

Contact:

Thermo Fisher Scientific Inc.
Media Contact:
Ron O’Brien, 781-622-1242
ron.obrien@thermofisher.com 
or
Investor Contact:
Ken Apicerno, 781-622-1294
ken.apicerno@thermofisher.com 
www.thermofisher.com